Global Recombinant DNA Technology Market

Recombinant DNA Technology Market Size, Share, Growth Analysis, By Product (Medical, Non-medical), By Component (Expression System, Cloning Vector), By Application (Food & Agriculture, Health & Disease), By End Use, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35H2067 | Region: Global | Published Date: December, 2025
Pages: 242 |Tables: 124 |Figures: 77

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Recombinant DNA Technology Market size was valued at USD 167.16 Billion in 2024 and is poised to grow from USD 179.7 Billion in 2025 to USD 320.49 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026–2033). 

    These participants are working together in alliances to provide their services in a variety of life science fields. Also, as a realistic tactic to maintain competitiveness in the market, companies are growing constantly their manufacturing facilities. 'Thermo Fisher Scientific (US) ', 'Roche Holding AG (Switzerland) ', 'Merck KGaA (Germany) ', 'Agilent Technologies (US) ', 'Bio-Rad Laboratories (US) ', 'Illumina (US) ', 'Danaher Corporation (US) ', 'Sartorius AG (Germany) ', 'Lonza Group (Switzerland) ', 'Charles River Laboratories (US) ', 'GenScript Biotech Corporation (China) ', 'Twist Bioscience (US) ', 'Ginkgo Bioworks (US) ', 'Amyris (US) ', 'Synthetic Genomics (US) ', 'Intrexon (US) ', 'PerkinElmer (US) ', 'Eurofins Scientific (Luxembourg) '

    During the forecast period, market expansion is expected to be driven by increasing strategic collaborations between leading market players to advance recombinant DNA technology. To create novel therapeutics based on recombinant DNA technologies, key market players strategically work with large biopharmaceutical companies and research institutions. Such market-wide strategic alliances are anticipated to spur market expansion soon.

    A large amount of public acceptance is now being acquired for the development of genetically modified crops in agriculture to increase yield and resistance to herbicides or pesticides. The genetically modified tomato CGN-89564-2 was among the first commercially available genetically engineered crop items to be granted a license for human consumption. Also dependent on DNA molecular marker technologies are the identification, evaluation, mining, and innovation of plant germplasm resources. Thus, it is expected that increasing RDT being used in food and agriculture will drive the original study segment's growth. Research on genetically modified organisms (GMOs), such as that on microorganisms that are regarded as bio degraders and generators of clean fuel, helps a wide range of additional sectors. Numerous human and plant illnesses are treated with genetically modified vaccinations. Recombinant DNA technology has opened up a variety of potential opportunities and prospects for creating a variety of therapeutic items with immediate effects in medical genetics and biomedicine. This is achieved by altering microbes, animals, and plants to produce medically valuable compounds.

    North America dominated the global market. The largest portion of the North American continent can be ascribed to the country's high concentration of biopharmaceutical manufacturing companies. Development aid has also been aided by the existence of powerful regulatory bodies that can keep an eye on the numerous ethical and scientific issues raised by the use of technology.

    Related Reports

    Recombinant Protein Market
    Buy Now GET FREE SAMPLE
    DNA Synthesis Market
    Buy Now GET FREE SAMPLE
    Recombinant Vaccines Market
    Buy Now GET FREE SAMPLE
    DNA Polymerase Market
    Buy Now GET FREE SAMPLE
    Gene Amplification Technologies Market
    Buy Now GET FREE SAMPLE
    CRISPR Technology Market
    Buy Now GET FREE SAMPLE
    Transfection Technologies Market
    Buy Now GET FREE SAMPLE
    Gene Therapy Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Recombinant DNA Technology Market

    Report ID: SQMIG35H2067

    $5,300
    BUY NOW